  |
 | Up a level |
Pertseva, T.O. and Borisova, I.S. (2018) Mathematical model of pneumonia associated with immunity disorders poor outcome forecasting in patients on the background of oncogematological pathology. Modern Scientific Researches, 3. pp. 68-76.
Pertseva, T.O. and Konopkina, L.І. and Shchudro, O.O. (2017) Adherence to continuous inhalation therapy in patient with chronic obstructive pulmonary disease, living in the Dnieper region. The Pharma Innovation Journal, 6 (4). pp. 33-35. ISSN 2349-8242 (print), 2277- 7695 (online)
Pertseva, T.O. and Mihailichenko, D.S. (2017) Changes in systemic inflammation markers and severity of symptoms in chronic obstructive pulmonary disease patients receiving adequate basic therapy. The Pharma Innovation Journal, 6 (2). pp. 93-96. ISSN 2349-8242 (print), 2277- 7695 (online)
Pertseva, T.O. and Bogatska, K.E. and Kireyeva, T.V. and Dmytrychenko, V.V. (2017) The experience of bronchiectasis severity index usage in the patients with non-cystic fibrosis bronchiectasis. Медичні перспективи, Т. 22 (№3 ч.1). pp. 140-141. ISSN 2307-0404
Pertseva, T.O. and Konopkina, L.І. and Huba, Yu.V. and Veresa, O.V. (2016) Diagnostic significance of questionnaire surveys for diagnosis of mental disorders in patients with chronic obstructive pulmonary disease. The Pharma Innovation Journal, 5 (8). pp. 39-41. ISSN 2349-8242 (print), 2277- 7695 (online)
Pertseva, T.O. and Kireyeva, T.V. and Kravchenko, N.K. (2015) CAP in pregnant: the connection between inflammatory biomarkers and efficacy of antibacterial treatment. The Pharma Innovation Journal, № 4 (2). pp. 4-6.
Pertseva, T.O. and Konopkina, L.І. and Yakovleva, V.H. (2015) Effects of Two-Component Standard Treatment of Chronic Obstructive Pulmonary Disease on Platelet-Vessel Wall Interaction Component and Coagulation Component of Hemostasis. The Pharma Innovation Journal, № 4 (7). pp. 85-89.
